Calcium Gluconate Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Calcium Gluconate Market is Segmented by Grade (Pharmaceutical Grade, Food Grade, and Industrial Grade), by Form (Powder, Liquid), by Application (Food and Beverage, Pharmaceuticals, Personal Care Products, Animal Feed, and More), and by Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Calcium Gluconate Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Calcium Gluconate Market with other markets in Food & Beverage Industry

Calcium Gluconate Market Analysis by Mordor Intelligence

The calcium gluconate market is valued at USD 105.94 billion in 2025 and is expected to reach USD 137.73 billion by 2030, growing at a CAGR of 5.39%. The pharmaceutical sector drives this growth, as calcium gluconate provides superior bioavailability compared to other calcium salts, making it essential for intravenous treatment of hypocalcemia in both human and veterinary medicine. The market expansion is supported by developments in personal care delivery systems, increased demand for clean-label food fortification, and government nutrition initiatives. The Asia-Pacific region dominates consumption patterns due to widespread dietary calcium deficiency, while North America experiences the highest growth rate, driven by strong fortification policies and an aging population seeking easily absorbable calcium supplements. Market stability is maintained by vertically integrated manufacturers who control the entire production process from gluconic acid fermentation to final dosage formulation, reducing raw material supply risks. However, increasing production costs, the emergence of alternative chelates, and strict regulations for injectable products moderate the market's growth potential.

Key Report Takeaways

  • By grade, pharmaceutical-grade products held 46.24% of the calcium gluconate market share in 2024 and are forecast to post a 6.34% CAGR by 2030.
  • By form, powder variants captured 56.29% of the calcium gluconate market size in 2024, whereas liquid solutions are projected to expand at 6.89% through 2030.
  • By application, personal care is the fastest-growing segment at 6.59% CAGR, while pharmaceutical uses remained the largest revenue contributor in 2024 with 39.48% revenue share.
  • By geography, Asia-Pacific commanded 33.17% of 2024 revenue; North America is set to grow at 6.45% CAGR through 2030.

Segment Analysis

By Grade: Pharmaceutical Dominance Drives Quality Standards

Pharmaceutical-grade calcium gluconate accounts for 46.24% of the market revenue in 2024, driven by its critical role in acute-care medical protocols. The segment projects a CAGR of 6.34% through 2030, supported by rising hospital admissions and emergency care needs. Suppliers ensure product quality through vertical integration, controlling processes from gluconic-acid fermentation to aseptic vial filling. This integrated approach maintains product standards and reduces contamination risks. The veterinary pharmaceutical sector demonstrates increased demand from expanding dairy operations and livestock healthcare requirements, sustaining high utilization of pharmacopoeial-grade production facilities.

Food-grade calcium gluconate, operating under Codex standards, experiences increased adoption in bakery premixes, beverage bases, and meat alternatives. The segment expands through rising consumer awareness of calcium fortification benefits. Market growth continues as fortified products expand their retail presence, supporting steady production volumes and creating manufacturer opportunities. The industrial grade segment focuses on specific applications, mainly concrete additives and specialty chemical production where chelation properties take precedence over purity requirements. These applications include water treatment and metal surface treatments. This market segmentation allows manufacturers to address varying purity needs while maintaining distinct pricing structures, supporting efficient resource allocation and market stability.

Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Form: Powder Practicality Versus Liquid Bioavailability

Powder format accounts for 56.29% of calcium gluconate shipments in 2024. This dominance stems from its efficient transportation capabilities, compatibility with tablet manufacturing processes, and superior shelf stability without causing issues. The format's cost-effectiveness supports large-scale fortification programs, including national flour initiatives, school meal supplementation, and public health campaigns. The market maintains stability through annual supply agreements with global grain millers. In animal feed applications, the powder format is crucial for uniform mixing during pellet production. The format also enables manufacturers to develop customized formulations for various end-user needs.

The liquid solutions segment is advancing at 6.89% CAGR. Healthcare sector requirements for ready-to-use formulations primarily drive this growth. Single-dose ampoules minimize preparation errors during emergencies, while infusion centers use premixed bags to improve operational efficiency. The format is essential in intensive care units, pediatric wards, and emergency departments where quick administration is necessary. Nutraceutical manufacturers utilize the format's favorable taste profile to provide alternatives to traditional pills. The segment's growth is further supported by hospitals' adoption of just-in-time inventory systems and increased demand for convenient dosage forms in home healthcare. Recent improvements in packaging and preservation technologies have enhanced product shelf life and sterility maintenance.

By Application: Pharmaceutical Leadership Meets Personal Care Innovation

Pharmaceutical applications dominated calcium gluconate sales in 2024, accounting for 39.48% of the market. The segment expanded due to broader clinical applications, including hypocalcemia treatment, calcium channel blocker overdose management, and cardioprotection during high-dose chemotherapy. The compound's proven efficacy in treating hypocalcemia has secured its inclusion in emergency medicine protocols and standard hospital formularies. In veterinary medicine, calcium gluconate is crucial for treating parturient paresis in dairy cattle, with veterinarians preferring it over calcium chloride due to its non-irritating properties. The pharmaceutical segment maintains market strength through regulatory compliance and GMP manufacturing standards, enabling premium pricing. The rising incidence of calcium-related disorders and an aging population further reinforce the segment's market position.

The personal care segment exhibits the highest growth rate at 6.59% CAGR during the forecast period, supported by technological advancements. Mibelle Biochemistry's EpiCalsome™ technology employs nano-vesicles for calcium delivery, enhancing epidermal junction strength and wound healing properties. This development has increased research activities in calcium-based skincare formulations. Premium skincare brands use calcium gluconate in scalp serums and anti-aging masks as a bioactive ingredient rather than a texturizer. The compound's influence on cellular signaling and skin barrier function has expanded its use in dermatological products. Food and beverage fortification and feed additive segments show consistent growth, while the construction industry uses the compound as a set-retarder in specialty cement applications, highlighting calcium gluconate's industrial versatility. The compound's applications across multiple industries support ongoing market growth and technical development.

Calcium Gluconate Market: Market Share by Application
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

Asia-Pacific held 33.17% of global revenue in 2024. The region's chronic dietary deficiencies prompt physicians and nutritionists to recommend prescription and over-the-counter supplementation programs. The nutritional gaps across developing nations require comprehensive supplementation strategies. China's fermentation facilities supply both domestic and export markets, ensuring the availability of food fortification and injectable formulations. The country's manufacturing infrastructure supports production capabilities to meet regional and international demand. India's public health initiatives, including fortification programs in school lunches, utilize domestic pharmaceutical manufacturing to control costs. These programs address calcium deficiency among school-age children and reflect the government's focus on nutritional improvement.

North America shows the highest growth rate at 6.45% CAGR through 2030, driven by the FDA's fortification regulations for plant-based milk alternatives. Consumer transition to plant-based diets requires enhanced calcium fortification in alternative products. The Dietary Guidelines for Americans include fortified soy beverages in the dairy category based on their nutrient profile. These guidelines emphasize products with higher calcium, and other nutrients, while limiting saturated fat and added sugars. The region's aging population increases supplement use, particularly among those aged 65 and above seeking bone health support. Hospital purchasing groups maintain long-term contracts for preservative-free injectable formulations. The United States-Canada trade benefits from aligned USP monographs, enabling efficient sterile manufacturing across North American markets.

Europe maintains demand through pharmaceutical and bakery fortification channels. The United Kingdom's mandatory calcium fortification in wheat flour supports population-wide calcium intake through staple foods. German hospitals provide demand for calcium gluconate ampoules in emergency care, particularly for hypocalcemia and cardiac emergencies. Latin America and Africa show growth potential, with Brazil's beverage industry developing gluconate-fortified sports drinks. Nigerian dairy cooperatives are evaluating injectable solutions for livestock care to address calcium deficiency in dairy cattle. Despite distribution challenges in these regions, increased investment in consumer education and market development indicates expansion opportunities. The emphasis on preventive healthcare and nutritional supplementation suggests growth potential in these emerging markets.

By Region, Global
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The calcium gluconate market maintains moderate concentration, with key players including Jungbunzlauer, Corbion, and BASF operating integrated production chains. These companies convert raw glucose into high-purity gluconate and finished dosages. Their control over fermentation yields and purification resins ensures batch uniformity, which appeals to pharmaceutical buyers requiring consistent elemental calcium levels. The companies maintain strategic plants in China and Austria to optimize logistics for regional demand, while implementing dual-sourcing programs to ensure supply security for multinational customers.

Jungbunzlauer utilizes its proprietary Aspergillus niger strain to reduce fermentation cycle time, resulting in lower utility costs and minimal waste effluent. Corbion specializes in downstream granulation technologies to improve powder flow, enabling faster compression speeds for tablet manufacturers. BASF maintains application laboratories to develop fortification recipes with dairy and beverage companies, integrating its ingredient specifications into final product formulations to secure repeat orders.

Mid-sized companies focus on specialized market segments. For instance, Somerset Therapeutics provides bar-coded pre-filled syringes to ambulatory-surgery centers. Evonik develops amine co-products to enhance gluconate set-retarder properties for construction composites. Balchem's acquisition of Kappa Bioscience combines vitamin K2 with calcium gluconate, enabling bundled offerings for orthopedic supplement brands. These specialized market approaches increase competitive dynamics while maintaining overall market concentration, supporting price stability and continued product innovation in the calcium gluconate market.

Calcium Gluconate Industry Leaders

  1. Jungbunzlauer AG

  2. Corbion N.V.

  3. Akzo Nobel N.V.

  4. Spectrum Chemical Manufacturing Corp.

  5. Tomita Pharmaceutical Co., Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
Akzo Nobel N.V, Spectrum Chemical Manufacturing Corp, Alfa Aesar, Westco Chemicals Inc, Noah Technologies Corporation
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • March 2025: Haleon extended its Caltrate brand to the Philippines to address widespread calcium deficiency in expectant mothers. This expansion is part of Haleon's broader strategy to replicate its success in China by raising awareness about calcium deficiency and providing solutions. In the Philippines, Haleon is reaching out to gynecologists to educate them on the importance of calcium supplementation during pregnancy and offering bone density tests in clinics and stores.
  • November 2024: Evonik is expanding its specialty-amine production capacity in Nanjing, China, to meet the growing demand for construction and automotive additives, specifically for polyurethane and epoxy curing agents. This expansion, at their existing site, aims to enhance their amine portfolio and strengthen their competitive position in the Chinese market and globally.

Table of Contents for Calcium Gluconate Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Calcium Deficiency Disorders
    • 4.2.2 Growing Geriatric Population Worldwide
    • 4.2.3 Expanding Nutraceutical and Dietary Supplement Markets
    • 4.2.4 Government Nutrition Initiatives and Fortification Policies
    • 4.2.5 Surging Demand in Veterinary Medicine
    • 4.2.6 Increasing Adoption in Food and Beverage Fortification
  • 4.3 Market Restraints
    • 4.3.1 High Production and Purification Costs
    • 4.3.2 Competition from Alternative Calcium Supplements
    • 4.3.3 Regulatory Hurdles for Injectable Formulations
    • 4.3.4 Limited Consumer Awareness in Emerging Markets
  • 4.4 Supply-Chain Analysis
  • 4.5 Regulatory Outlook
  • 4.6 Porter's Five Forces
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Grade
    • 5.1.1 Pharmaceutical Grade
    • 5.1.2 Food Grade
    • 5.1.3 Industrial Grade
  • 5.2 By Form
    • 5.2.1 Powder
    • 5.2.2 Liquid
  • 5.3 By Application
    • 5.3.1 Food and Beverage
    • 5.3.2 Pharmaceutical
    • 5.3.3 Personal Care Products
    • 5.3.4 Animal Feed
    • 5.3.5 Construction and Industrial Additives
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
    • 5.4.2.1 United Kingdom
    • 5.4.2.2 Germany
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Russia
    • 5.4.2.7 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
    • 5.4.5.1 Saudi Arabia
    • 5.4.5.2 South Africa
    • 5.4.5.3 Rest of Middle East and Africa

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Ranking Analysis
  • 6.4 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
    • 6.4.1 Akzo Nobel N.V.
    • 6.4.2 Spectrum Chemical Manufacturing Corp.
    • 6.4.3 Jungbunzlauer AG
    • 6.4.4 Corbion N.V.
    • 6.4.5 Roquette Frères
    • 6.4.6 Tomita Pharmaceutical
    • 6.4.7 Hameln Pharma
    • 6.4.8 Fresenius Kabi
    • 6.4.9 Amneal Pharmaceuticals
    • 6.4.10 Westco Chemicals
    • 6.4.11 Alfa Aesar (Thermo Fisher)
    • 6.4.12 Noah Technologies
    • 6.4.13 Glucona America
    • 6.4.14 SPI Pharma
    • 6.4.15 Evonik Industries
    • 6.4.16 BASF SE
    • 6.4.17 East African Remedies
    • 6.4.18 Shalina Laboratories
    • 6.4.19 Lianyungang Zhonghong Chemical
    • 6.4.20 American International Chemical (AIC)

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Calcium Gluconate Market Report Scope

Global calcium gluconate market is segmented by application (which includes food & beverage, pharmaceuticals, personal care products, and animal feed); and by geography (which includes North America, Europe, Asia-Pacific, South America, and the Middle East and Africa).

By Grade Pharmaceutical Grade
Food Grade
Industrial Grade
By Form Powder
Liquid
By Application Food and Beverage
Pharmaceutical
Personal Care Products
Animal Feed
Construction and Industrial Additives
By Geography North America United States
Canada
Mexico
Rest of North America
Europe United Kingdom
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia-Pacific China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa Saudi Arabia
South Africa
Rest of Middle East and Africa
By Grade
Pharmaceutical Grade
Food Grade
Industrial Grade
By Form
Powder
Liquid
By Application
Food and Beverage
Pharmaceutical
Personal Care Products
Animal Feed
Construction and Industrial Additives
By Geography
North America United States
Canada
Mexico
Rest of North America
Europe United Kingdom
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia-Pacific China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa Saudi Arabia
South Africa
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the projected value of the calcium gluconate market by 2030?

The calcium gluconate market is forecast to reach USD 137.73 billion by 2030, growing at a 5.39% CAGR.

Which region is growing the fastest in the calcium gluconate market?

North America is expanding at a 6.45% CAGR through 2030, propelled by fortification policies and an aging population that seeks highly absorbable calcium.

How big is the pharmaceutical-grade segment within the calcium gluconate market?

Pharmaceutical-grade products accounted for 46.24% of revenue in 2024 and are on track for a 6.34% CAGR, underscoring their dominance in therapeutic applications.

Why do hospitals prefer calcium gluconate over calcium chloride for hypocalcemia emergencies?

Calcium gluconate delivers ionic calcium quickly yet causes less tissue irritation and boasts a safer hemodynamic profile, making it the standard intravenous choice in many emergency protocols.

Page last updated on: July 5, 2025

Calcium Gluconate Market Report Snapshots